In the last few decades, the field of biomedical engineering has witnessed revolutionary advancements in artificial intelligence (AI). This abstract explores the anarchic developments in AI, specifically focusing on the implementation of Deep Neural Networks (DNN) and Artificial Neural Networks (ANN) in the realm of biomedical engineering. The objective is to delve into the intricacies of these technologies, exploring their potential and paving the way for further exploration through ongoing hypothetical ideations. This analytical and pragmatic research is centered around the utilization of DNN and ANN for the comprehensive analysis of biomedical data. The primary focus is on gathering substantial medication data-fusions, utilizing the theoretical knowledge embedded in these advanced neural network models. The overarching goal is to contribute to the expansion of real-time biochemical experiments, particularly in the pharmaceutical sector. Through the implementation of cutting-edge AI technologies, this research aims to bridge the gap between theoretical ideations and practical applications in the field of healthcare.
No takes yet. Share an insight, caveat, or question.
Sarker et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: